- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 4.18M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $40.32M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $44.3M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $191.06M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $196.49M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $271.65M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $276.7M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 4.09M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $2.46M |
| Capex | Q1 2025 · Mar 31, 2024 | $24K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $247K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $81.25M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $84.56M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$1.15 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$1.15 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$4.69M |